Titan Biotech Share Price Hits 5% Upper Circuit as Board Approves 1:4 Bonus Shares and Share Capital Increase

On September 3, 2026, Titan Biotech Limited's Board of Directors approved the issuance of bonus shares and an increase in authorised share capital, as per the exchange filings.  

These decisions are subject to shareholder approval at the upcoming Annual General Meeting (AGM). 

Bonus Shares Issuance 

The company plans to issue bonus equity shares in a 1:4 ratio, meaning 1 new fully paid-up bonus equity share of ₹2 each for every 4 existing fully paid-up equity shares of ₹2 each. The record date for determining eligible shareholders will be announced later.  

The bonus shares will be issued from the securities premium account, retained earnings, or other reserves available as of March 31, 2026. 

Increase in Authorised Share Capital 

The Board has approved increasing the authorised share capital from ₹10,00,00,000 to ₹10,40,00,000. This will involve amending Clause 5 of the Memorandum of Association, subject to shareholder approval. The new authorised share capital will be divided into 5,20,00,000 equity shares of ₹2 each. 

Re-appointment of Independent Director 

Mr. Rohit Jain has been recommended for re-appointment as an Independent Director for a second term of 5 years, starting September 30, 2026. This is subject to shareholder approval. 

Annual General Meeting Details 

The 34th AGM of Titan Biotech Limited is scheduled for September 29, 2026, via video conferencing. The cut-off date for voting eligibility is September 22, 2026, and the book closure dates are from September 23 to September 29, 2026. 

Dividend Announcement 

The Board has recommended a final dividend of ₹0.50 per share, with the record date set for September 22, 2026. 

Read More: Tata Motors Share Price in Focus; Iveco Acquisition Gets Final ECB Approval! 

Titan Biotech Share Price Performance 

As of September 03, 2026, at 1:36 PM, Titan Biotech share price on BSE was trading at ₹435.55, up by 4.99% from the previous closing price. 

Conclusion 

Titan Biotech Limited has approved the issuance of 1,03,29,625 bonus shares in a 1:4 ratio and increased its authorised share capital to ₹10,40,00,000. The AGM is scheduled for September 29, 2026, where these proposals will be put to a shareholder vote. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.